9892--2/27/2007--BARD_C_R_INC_/NJ/

related topics
{product, liability, claim}
{product, market, service}
{customer, product, revenue}
{property, intellectual, protect}
{regulation, change, law}
Defects or failures associated with our products could lead to recalls or safety alerts, negative publicity regarding the company and litigation which could adversely affect our business. We face intense competition from other companies, and an inability to continue to effectively develop, acquire and/or market new products and technologies may prevent us from being competitive, or achieving significant market penetration or improved operating results. Domestic and foreign legislative or administrative reforms resulting in restrictive reimbursement practices of third-party payors and cost containment measures could decrease the demand for products purchased by our customers, the prices that our customers are willing to pay for those products and the number of procedures using our devices. An interruption in our ability to manufacture our products or an inability to obtain key components or raw materials may adversely affect our business. We are subject to a comprehensive system of federal and state laws and regulations, and we could be the subject of an enforcement action or face lawsuits and monetary or equitable judgments. We are substantially dependent on patent and proprietary rights and could incur significant costs defending and protecting those rights or face restrictions or additional costs in connection with the sale of our products.

Full 10-K form ▸

related documents
10456--2/26/2008--BAXTER_INTERNATIONAL_INC
9892--2/26/2008--BARD_C_R_INC_/NJ/
10456--3/7/2006--BAXTER_INTERNATIONAL_INC
9892--2/26/2009--BARD_C_R_INC_/NJ/
9892--2/25/2010--BARD_C_R_INC_/NJ/
27096--9/13/2006--DATASCOPE_CORP
27096--9/12/2007--DATASCOPE_CORP
57528--2/22/2008--LANCE_INC
1114200--2/27/2008--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC
764579--3/19/2008--CAS_MEDICAL_SYSTEMS_INC
718924--12/27/2006--SPAN_AMERICA_MEDICAL_SYSTEMS_INC
8146--4/16/2008--ASTRO_MED_INC_/NEW/
1110783--11/2/2006--MONSANTO_CO_/NEW/
943894--3/31/2006--EZENIA_INC
1282543--3/30/2010--AFFIRMATIVE_INSURANCE_HOLDINGS_INC
887497--7/14/2006--HI_TECH_PHARMACAL_CO_INC
874734--3/8/2010--OSTEOTECH_INC
806517--3/24/2008--PSYCHEMEDICS_CORP
718924--12/28/2007--SPAN_AMERICA_MEDICAL_SYSTEMS_INC
909832--10/16/2008--COSTCO_WHOLESALE_CORP_/NEW
350692--12/28/2007--DELPHAX_TECHNOLOGIES_INC
855683--3/17/2009--MILESTONE_SCIENTIFIC_INC/NJ
1015155--3/10/2006--CHARLES_&_COLVARD_LTD
8146--4/16/2007--ASTRO_MED_INC_/NEW/
1114200--3/1/2010--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC
894237--6/29/2006--VISION_SCIENCES_INC_/DE/
1158387--3/20/2009--VISCOUNT_SYSTEMS_INC
874734--3/14/2007--OSTEOTECH_INC
931015--3/1/2006--POLARIS_INDUSTRIES_INC/MN
277509--2/27/2008--FEDERAL_SIGNAL_CORP_/DE/